{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T03:25:17Z","timestamp":1773804317836,"version":"3.50.1"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1097\/dss.0000000000001804","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T19:35:50Z","timestamp":1553110550000},"page":"1432-1434","source":"Crossref","is-referenced-by-count":8,"title":["Permanent Cutaneous Adverse Events After Injection With Deoxycholic Acid"],"prefix":"10.1097","volume":"45","author":[{"given":"Mary R.","family":"Ramirez","sequence":"first","affiliation":[{"name":"Department of Dermatology, Duke University Medical Center Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"Marinaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandy L.","family":"Warthan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude S.","family":"Burton","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Duke University Medical CenterDurham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230814","first-page":"1","article-title":"Sodium deoxycholate for submental contouring","volume":"21","author":"Humphrey","year":"2016","journal-title":"Skin Ther Lett"},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"e1155","DOI":"10.1097\/GOX.0000000000001155","article-title":"Noninvasive submental fat compartment treatment","volume":"4","author":"Shamban","year":"2016","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"R3-20230814","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/jdv.12377","article-title":"Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study","volume":"28","author":"Ascher","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jaad.2016.04.028","article-title":"ATX-101 for reduction of submental fat: a phase III randomized controlled trial","volume":"75","author":"Humphrey","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"R5-20230814","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/asj\/sjy008","article-title":"Efficacy and safety of ATX-101 by treatment session: pooled analysis of data from the phase 3 REFINE trials","volume":"38","author":"Dayan","year":"2018","journal-title":"Aesthet Surg J"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000001804","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T19:38:43Z","timestamp":1692041923000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000001804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":5,"aliases":["10.1097\/00042728-900000000-98503"],"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000001804","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}